Extramedullary hematopoiesis in myeloproliferative neoplasms: Pathophysiology and treatment strategies

被引:2
|
作者
Chernak, Brian J. [1 ,2 ]
Rampal, Raajit K. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Leukemia, 1275 York Ave, New York, NY 10021 USA
[2] NewYork Presbyterian Weill Cornell Med Ctr, Dept Med, New York, NY 10021 USA
关键词
CHRONIC IDIOPATHIC MYELOFIBROSIS; EXTRA-MEDULLARY HEMATOPOIESIS; AGNOGENIC MYELOID METAPLASIA; INTERNATIONAL-WORKING-GROUP; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; RESPONSE CRITERIA; THERAPY; RUXOLITINIB; EFFICACY;
D O I
10.1016/bs.ircmb.2021.07.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extramedullary hematopoiesis (EMH) is often a physiologic response to ineffective marrow production of hematologic cells. While this can be found incidentally in various physiologic and pathophysiologic states, the myeloproliferative neoplasms (MPNs) are some of the most common underlying conditions found in patients with EMH. Although this process can assist with hematologic production in defective states, the burden of EMH can lead to symptomatic discomfort and mechanical obstructive complications, most commonly in the spleen and liver. Here we describe the pathophysiology of EMH, treatment options, including medical, surgical and radiation-based approaches.
引用
收藏
页码:97 / 116
页数:20
相关论文
共 50 条
  • [21] Different impact of calreticulin mutations on human hematopoiesis in myeloproliferative neoplasms
    El-Khoury, Mira
    Cabagnols, Xenia
    Mosca, Matthieu
    Vertenoeil, Gaelle
    Marzac, Christophe
    Favale, Fabrizia
    Bluteau, Olivier
    Lorre, Florence
    Tisserand, Amandine
    Moraes, Graciela Rabadan
    Ugo, Valerie
    Ianotto, Jean-Christophe
    Rey, Jerome
    Solary, Eric
    Roy, Lydia
    Rameau, Philippe
    Debili, Najet
    Pasquier, Florence
    Casadevall, Nicole
    Marty, Caroline
    Constantinescu, Stefan N.
    Raslova, Hana
    Vainchenker, William
    Plo, Isabelle
    ONCOGENE, 2020, 39 (31) : 5323 - 5337
  • [22] MARKERS OF CLONAL HEMATOPOIESIS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
    Polushkina, L.
    Martynkevich, I.
    Shuvaev, V.
    Petrova, E.
    Fominykh, M.
    Martynenko, L.
    Cybakova, N.
    Petrova, M.
    Shabanova, E.
    Zotova, I.
    Zamotina, T.
    Zhernyakova, A.
    Abdulkadyrov, K.
    HAEMATOLOGICA, 2015, 100 : 531 - 531
  • [23] Current treatment of myeloproliferative neoplasms
    Al-Ali, Haifa Kathrin
    LEUKEMIA RESEARCH, 2018, 73 : S3 - S3
  • [24] CURRENT TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS
    Al-Ali, Haifa Kathrin
    LEUKEMIA RESEARCH, 2016, 49 : S9 - S10
  • [25] Interferons in the treatment of myeloproliferative neoplasms
    Vachhani, Pankit
    Mascarenhas, John
    Bose, Prithviraj
    Hobbs, Gabriela
    Yacoub, Abdulraheem
    Palmer, Jeanne M.
    Gerds, Aaron T.
    Masarova, Lucia
    Kuykendall, Andrew T.
    Rampal, Raajit K.
    Mesa, Ruben
    Verstovsek, Srdan
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2024, 15
  • [26] Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease
    Sanber, Khaled
    Ye, Kevin
    Tsai, Hua-Ling
    Newman, Matthew
    Webster, Jonathan A.
    Gojo, Ivana
    Ghiaur, Gabriel
    Prince, Gabrielle T.
    Gondek, Lukasz P.
    Smith, B. Douglas
    Levis, Mark J.
    DeZern, Amy E.
    Ambinder, Alexander J.
    Dalton, William B.
    Jain, Tania
    LEUKEMIA & LYMPHOMA, 2023, 64 (04) : 846 - 855
  • [27] CURRENT TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS
    Al-Ali, Haifa Kathrin
    LEUKEMIA RESEARCH, 2017, 61 : S8 - S8
  • [28] Cutaneous involvement in Ph-negative myeloproliferative neoplasms: from extramedullary hematopoiesis to myeloid metastasis with histiocytic differentiation. A systematic review of the literature
    Bonometti, Arturo
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2023, 62 (10) : 1228 - 1236
  • [29] Presence of polyclonal hematopoiesis in females with Ph-negative myeloproliferative neoplasms
    Swierczek, S.
    Lima, L. T.
    Tashi, T.
    Kim, S. J.
    Gregg, X. T.
    Prchal, J. T.
    LEUKEMIA, 2015, 29 (12) : 2432 - 2434
  • [30] Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer
    Barbui, Tiziano
    Gavazzi, Antonello
    Sciatti, Edoardo
    Finazzi, Maria Chiara
    Ghirardi, Arianna
    Carioli, Greta
    Carobbio, Alessandra
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2023, 18 (04) : 105 - 112